Home » Topics » BioWorld Science

BioWorld Science
RSS

Cirrhosis to liver cancer progression still mysterious

Oct. 31, 2019

Convertible CARs to the reservoir rescue?

Oct. 31, 2019

Rightsizing brain activity increases lifespan, but REST is not all good

Oct. 31, 2019

miRagen Therapeutics reports on miR-29 programs

Oct. 30, 2019

CytomX initiates phase II study of CX-072 with ipilimumab in relapsed or refractory melanoma

Oct. 30, 2019

FDA places partial hold on AVXS-101 intrathecal clinical trials

Oct. 30, 2019

European Commission approves Dupixent for chronic rhinosinusitis with nasal polyposis

Oct. 30, 2019

Dosing begins in first-in-human study of UCARTCS1 for relapsed/refractory multiple myeloma

Oct. 30, 2019

Proline derivatives identified at Qingdao Marine Biomedical Research Institute

Oct. 30, 2019

Dalian Institute of Chemical Physics CAS patents muscarinic M1/ M3 receptor antagonists

Oct. 30, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...